Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant 02 October 2008 Expression Analysis, the industry’s leading provider of genomic services for clinical trials and research, announces they will award a Genome Wide Association Study (GWAS) Data Analysis and Resequencing Grant.
Public-private Research Partnership Announces £5M of Projects to Accelerate Biopharmaceutical Drug Development 01 October 2008 Bioprocessing research in the UK has received a £5M boost following today’s announcement of nine projects to be funded by awards from the Bioprocessing Research Industry Club (BRIC).
The X-MAN Steps-Out: Horizon Discovery Sign Screening and License Agreements with Agios Pharmaceuticals 01 October 2008 Horizon Discovery (Horizon) today announced it has signed two commercial agreements with a ground-breaking U.S. cancer start-up; Agios Pharmaceuticals (Agios), relating to its X-MAN technology.
Sepsis: Broad-Spectrum PCR-Test Receives CE-IVD Approval 30 September 2008 SepsiTest™ is a novel PCR test for early and rapid diagnosis of sepsis. In less than four hours the broad-spectrum screening assay detects more than 345 relevant sepsis germs.
Tissue Proteomics Technology to Identify Protein Biomarkers of Metastasis 29 September 2008 Expression Pathology will collaborate with the Alberta Cancer Board, Tom Baker Cancer Centre (Calgary, Alberta) to identify protein biomarkers of breast cancer metastasis.
Gene Variant Boosts Risk of Fatty Liver Disease 26 September 2008 Researchers at UT Southwestern Medical Center have found that individuals who carry a specific form of the gene PNPLA3 have more fat in their livers and a greater risk of developing liver inflammation.
SIRS-Lab and DxS Enter Into Licensing Agreement for the Application of Scorpions® in Sepsis Test SIQNATURE™ 23 September 2008 Both companies have signed an EU-wide in-licensing agreement for the Scorpions® Technology including an option for worldwide IVD utilization.
Sequenom Announces Licensing Agreement with Genomic Nanosystems 23 September 2008 The license provides Sequenom with the exclusive right to use digital PCR methods for noninvasive prenatal diagnostics and analysis.